You are here:

Archived: choriogonadotropin alfa (Ovitrelle)

Advice

In the absence of a submission from the holder of the marketing authorisation

choriogonadotropin (Ovitrelle) is not recommended for use within NHS Scotland for women undergoing superovulation prior to assisted reproductive techniques such as in vitro fertilisation (IVF).

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHS Scotland.

Drug Details

Drug Name: choriogonadotropin alfa (Ovitrelle)
SMC Drug ID: 263/06
Manufacturer: Serono Ltd
Indication: Superovulation prior to assisted reproductive techniques such as in vitro fertilisation (IVF)
BNF Category:
Sub Category: 6.5 Hypothalamic and pituitary hormones and anti-oestrogens
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 8 May 2006

Current Advice

Abbreviated Submission 9 October 2006

Back